{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T18:17:17Z","timestamp":1787854637441,"version":"build-2784847793"},"reference-count":5,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"DOI":"10.1136\/ejhpharm-2026-005309","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:20:24Z","timestamp":1787851224000},"page":"ejhpharm-2026-005309","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Administrative delays in access to high-impact medicines: a patient safety risk"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8672-9075","authenticated-orcid":false,"given":"Silvia","family":"V\u00e1zquez-G\u00f3mez","sequence":"first","affiliation":[{"name":"Pharmacy, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora","family":"Feijoo-Mel\u00e9ndez","sequence":"additional","affiliation":[{"name":"Pharmacy, Hospital Universitario Lucus Augusti, Lugo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4020-4892","authenticated-orcid":false,"given":"Sandra","family":"Ca\u00ed\u00f1a L\u00f3pez","sequence":"additional","affiliation":[{"name":"Pharmacy, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"2026082710201733000_ejhpharm-2026-005309v1.1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.japh.2018.09.004","article-title":"Modeling specialty medicine access: Understanding key health system processes and players","volume":"59","author":"Cocohoba","year":"2019","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2026082710201733000_ejhpharm-2026-005309v1.2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.38182","article-title":"The Patient Experience of Prior Authorization for Cancer Care","volume":"6","author":"Chino","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026082710201733000_ejhpharm-2026-005309v1.3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1200\/OP.23.00031","article-title":"Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib","volume":"19","author":"Dagogo-Jack","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"2026082710201733000_ejhpharm-2026-005309v1.4","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2015.007260"},{"key":"2026082710201733000_ejhpharm-2026-005309v1.5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m4087","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis","volume":"371","author":"Hanna","year":"2020","journal-title":"BMJ"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2026-005309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:20:25Z","timestamp":1787851225000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2026-005309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":5,"alternative-id":["10.1136\/ejhpharm-2026-005309"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2026-005309","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}